Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MEDICINOVA INCMNOV · Entity 7011 | Vice President | January 09, 2024 | January 11, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MEDICINOVA INC
Report date January 09, 2024 · Filed January 11, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.40 · Expires 2033-01-31 | Direct | 84,000 |
Reported balance
After 2024-01-09 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-01-09 · Grant · Acquired 84,000 · Balance 84,000 F1: On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 09, 2024 Filed Jan 11, 2024 21:52 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 84,000 | $0.00 Strike: $2.40 | $0.00 |
DisclosureSEC source: 0001683168-24-000225 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,000 Underlying: Common Stock · 84,000 shares Expires 2033-01-31 F1 · balance_after: On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares. Read SEC document |
| January 23, 2023 Filed Jan 25, 2023 22:17 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 76,950 | $0.00 Strike: $2.25 | $0.00 |
DisclosureSEC source: 0001683168-23-000343 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,950 Underlying: Common Stock · 76,950 shares Expires 2032-01-26 F1 · balance_after: On January 27, 2022 the reporting person was granted an option to purchase 81,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2022. Such performance criteria for 2022 were achieved at the 95% attainment level, resulting in vesting of the option as to 76,950 shares. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 02:01 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 99,000 | $0.00 Strike: $5.92 | $0.00 |
DisclosureSEC source: 0001683168-22-000596 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2031-02-17 F1 · balance_after: On February 18, 2021, the reporting person was granted an option to purchase 180,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2021. Such performance criteria for 2021 were achieved at the 55% attainment level, resulting in vesting of the option as to 99,000 shares. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,318 | $0.00 Strike: $2.46 | $0.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · derivative · entry 4 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,932 Underlying: Common Stock · 11,318 shares Expires 2021-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 32,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · derivative · entry 3 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,000 shares Expires 2021-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 11,318 | $2.46 | $27,842.28 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · nonDerivative · entry 2 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,318 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 20, 2021 21:26 UTC | MEDICINOVA INC MNOV · Entity 7011 | Exercise / conversionCommon Stock | 32,000 | $2.54 | $81,280.00 |
DisclosureSEC source: 0001683168-21-002130 · ownership.xml · nonDerivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 02, 2021 Filed Feb 4, 2021 21:16 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 99,000 | $0.00 Strike: $6.89 | $0.00 |
DisclosureSEC source: 0001683168-21-000393 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,000 Underlying: Common Stock · 99,000 shares Expires 2030-01-08 F1 · balance_after: On January 09, 2020, the reporting person was granted an option to purchase 220,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2020. Such performance criteria for 2020 were achieved at the 45% attainment level, resulting in vesting of the option as to 99,000 shares. Read SEC document |
| January 09, 2020 Filed Jan 11, 2020 01:05 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 165,000 | $0.00 Strike: $9.67 | $0.00 |
DisclosureSEC source: 0001683168-20-000089 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 Underlying: Common Stock · 165,000 shares Expires 2029-01-14 F1 · balance_after: On January 15, 2019, the reporting person was granted an option to purchase 220,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2019. The performance criterial for 2019 were achieved at the 75% attainment level, resulting in vesting of the option as to 165,000 shares. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:23 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000149 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2028-01-05 F1 · balance_after: On January 6, 2018, the reporting person was granted an option to purchase 205,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 23:24 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000090 · obrien_f4-010618.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 200,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 22:30 UTC | MEDICINOVA INC MNOV · Entity 7011 | GrantEmployee Stock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000140 · obrien_f4.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 115,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.